Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHEMCHA: DP vs SP for Malaria Chemoprevention in Sickle Cell Anaemia
NCT04844099Phase 3Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Apr 2021
- Primary completion
- Jun 2023
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in malaria, sponsored by Liverpool School of Tropical Medicine. Started Apr 2021; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04844099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04844099.